Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients

AIM: To describe factors associated with treatment failure and frequency of resistance-associated substitutions (RAS). METHODS: Human immunodeficiency virus (HIV)/hepatitis C virus (HCV) coinfected patients starting a first direct-acting antiviral (DAA) regimen before February 2016 and included in t...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:World J Hepatol
Main Authors: Salmon, Dominique, Trimoulet, Pascale, Gilbert, Camille, Solas, Caroline, Lafourcade, Eva, Chas, Julie, Piroth, Lionel, Lacombe, Karine, Katlama, Christine, Peytavin, Gilles, Aumaitre, Hugues, Alric, Laurent, Boué, François, Morlat, Philippe, Poizot-Martin, Isabelle, Billaud, Eric, Rosenthal, Eric, Naqvi, Alissa, Miailhes, Patrick, Bani-Sadr, Firouzé, Esterle, Laure, Carrieri, Patrizia, Dabis, François, Sogni, Philippe, Wittkop, Linda
פורמט: Artigo
שפה:Inglês
יצא לאור: Baishideng Publishing Group Inc 2018
נושאים:
Observational Study
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6280155/
https://ncbi.nlm.nih.gov/pubmed/30533186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v10.i11.856
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים